Ktenders

Health & social care · UK-wide Upcoming

Qualified Person Service for Investigational Medicinal Products (IMP)

NHS Blood and Transplant · Expected to open December 2026

What this tender is

NHS Blood and Transplant is seeking suppliers for “Qualified Person Service for Investigational Medicinal Products (IMP)”. It is classed as health & social care services, with delivery across the UK or not tied to one region.

In the buyer's own words: NHS Blood and Transplant is seeking to appoint a suitably qualified and experienced supplier to provide Qualified Person services in support of its portfolio of Investigational Medicinal Product manufacturing projects. The proposed service may include: reviewing and providing regulatory and quality input into selected regulatory submissions; advising on applicable regulatory, Good Manufacturing Practice and quality-compliance requirements for biological and Advanced Therapy Medicinal Product manufacturing projects; providing regulatory, GMP and quality input into the design and development…

The procedure and any lots are set out in full on the official notice.

The estimated value is £216k, as stated by the buyer; the final value can differ.

Ktenders places each notice in a trade from the classification code the buyer chose and in a region from the delivery location it gives, so if the scope looks different from the trade shown here, the official notice is the one to trust.

Who it suits

This tender is most relevant to health & social care suppliers able to deliver across the UK or not tied to one region.

At this size it is within reach of many small suppliers, though the buyer may still ask for relevant experience, insurance and financial standing.

Public buyers in the UK must treat suppliers equally and explain how bids will be scored, so the selection and award criteria in the tender documents are the best guide to whether this opportunity is worth your time.

Before deciding to bid, read the full notice and any attached documents: they set out the exact requirements, selection criteria and how bids will be scored.

Key dates

The notice was published on 7 October 2026.

This is a pipeline notice: the buyer intends to run a procurement and expects it to open around December 2026. No bids can be submitted yet.

Pipeline notices give suppliers time to prepare. Many invite early market engagement — a questionnaire, a supplier day or a request for information — and taking part helps the buyer shape a tender that suits firms like yours. When the buyer publishes the full tender notice, it will appear on Ktenders with its closing date.

Dates in pipeline notices are estimates and often move, so register on the buyer's portal and check the official notice for updates rather than relying on the expected month alone.

Original notice text

NHS Blood and Transplant is seeking to appoint a suitably qualified and experienced supplier to provide Qualified Person services in support of its portfolio of Investigational Medicinal Product manufacturing projects.

The proposed service may include:

reviewing and providing regulatory and quality input into selected regulatory submissions;

advising on applicable regulatory, Good Manufacturing Practice and quality-compliance requirements for biological and Advanced Therapy Medicinal Product manufacturing projects;

providing regulatory, GMP and quality input into the design and development of selected manufacturing processes and facilities;

reviewing assigned batches and, where all applicable legal, regulatory, GMP, Clinical Trial Authorisation, Product Specification File and NHSBT quality-system requirements have been met, certifying batches for use in approved clinical trials;

mentoring selected NHSBT staff undertaking the process of obtaining Qualified Person registration; and

providing associated professional, regulatory and quality advice as required.

Each Qualified Person proposed by the supplier will be expected to hold and maintain the qualifications, professional eligibility and regulatory status required to act as a Qualified Person for Investigational Medicinal Products in the UK.

Proposed personnel should have recent and demonstrable experience of acting as a named Qualified Person on a UK Manufacturing and Import Authorisation for Investigational Medicinal Products, MIA(IMP), and of certifying IMP batches. Experience relating to biological, biotechnology, cell therapy and gene therapy medicinal products may also be required.

The current anticipated level of support is approximately 24 to 48 days per year, with at least 50% of the support delivered on NHSBT premises and the remaining support delivered remotely, subject to agreement.

The scope and requirements described in this notice are indicative and may be refined following preliminary market engagement.

More health & social care tenders

All health & social care tenders →

More tenders in UK-wide

All tenders in UK-wide →

Closing soon

All live tenders by trade →